Views: 1,282 | Downloads:
24
| Responses: 0
| XML | Respond to this article | Alert & updates | Request permissions | Email to a friend |
Original ArticleOpen Access
The Efficacy and Tolerability of an Angiotensin II Receptor Blocker, Telmisartan, in Thai Patients with Mild to Moderate Essential Hypertension
Buranakitjaroen P 
,
Phoojaroenchanachai M ,
Saravich S ,
Sangprasert P
,
Phoojaroenchanachai M ,
Saravich S ,
Sangprasert P This open-labeled single-blinded study was performed to evaluate the efficacy and tolerability
of telmisartan in the treatment of mild to moderate essential hypertension. Each patient was assigned
to take a placebo for 4 weeks followed by once daily-titrated telmisartan (40-80 mg) for 8 weeks.
"Office BP" and "24-hour ambulatory BP" measurements (24-h ABPM) were recorded as scheduled.
Thirty-one patients (10 males : 21 females) with a mean age of 48.1 years were enrolled. The final
SBP/DBP reductions of 14.6
เธ‘
14.2/9.9
เธ‘
6.2 mm Hg were obtained. Full response defined as office
DBP reduction of 2!:10 mm Hg from baseline and/or DBP
of telmisartan in the treatment of mild to moderate essential hypertension. Each patient was assigned
to take a placebo for 4 weeks followed by once daily-titrated telmisartan (40-80 mg) for 8 weeks.
"Office BP" and "24-hour ambulatory BP" measurements (24-h ABPM) were recorded as scheduled.
Thirty-one patients (10 males : 21 females) with a mean age of 48.1 years were enrolled. The final
SBP/DBP reductions of 14.6
เธ‘
14.2/9.9
เธ‘
6.2 mm Hg were obtained. Full response defined as office
DBP reduction of 2!:10 mm Hg from baseline and/or DBP
Download:
PDF